Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Motor Activity 1 Inflammation 1 Feeding Behavior 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Cachexia 1

Interventions

Capecitabine 6 Irinotecan 5 Fluorouracil 5 Cisplatin 5 Oxaliplatin 4 Leucovorin 4 Gemcitabine 4 apatinib 3 Sorafenib 3 Bevacizumab 3 tislelizumab 2 pembrolizumab 2 Sunitinib 2 Radiotherapy 2 Paclitaxel 2 Immune Checkpoint Inhibitors 2 Cyclophosphamide 2 Cetuximab 2 Aspirin 2 Ascorbic Acid 2 130-nm albumin-bound paclitaxel 2 spartalizumab 1 sintilimab 1 regorafenib 1 pyrotinib 1 pemigatinib 1 lutetium Lu 177 dotatate 1 huachansu 1 halofantrine 1 guadecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Digestive System Neoplasms × Body Height × Clear all

NCT03172403 2022-08-25

MYOCAC

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated

Gastrointestinal

Cachexia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡